Figure 1. Pathogenesis of myocarditis: the auto-inflammatory hypothesis. In myocarditis, a detrimental inflammatory response leads to cardiac damage, clinically manifested with contractile dysfunction. The pro-inflammatory cytokine interleukin (IL)-1 is of pivotal importance in the pathogenesis of myocardial inflammation. Inflammation of the heart results in myocardial injury. IL-1α is released from the dying myocardiocytes, together with intracellular debris and inflammatory mediators; these in turn activate a molecular complex known as the “inflammasome,” resulting in processing and release of active IL-1β by infiltrating inflammatory cells. Runaway cardiac inflammation ensues, leading to apoptosis of cardiomyocytes and loss of contractile tissue, cardiomyopathy, and heart failure. Given the dual efficacy against myocardial inflammation and contractile dysfunction, prompt pharmacologic inhibition of IL-1 can arrest the progression of uncontrolled inflammation, thus preventing extensive tissue damage and arrhythmic complications and restoring cardiac function.
Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This opinion article discusses the potential role of interleukin-1 in the pathogenesis of myocarditis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: